IHH Healthcare Berhad: Director Mehmet Ali Aydinlar Disposes Shares Outside Closed Period

Key Points from the Announcement

• Director Disposal of Shares: Mr. Mehmet Ali Aydinlar, Non-Executive Director of IHH Healthcare Berhad, has disposed significant amounts of ordinary shares in two separate transactions at the end of December 2025.
• Transaction Details:
  • First Transaction: On 29 December 2025, Mr. Aydinlar disposed 647,300 ordinary shares at a consideration of MYR 8.556 per share, representing 0.007% of the total shares.
  • Second Transaction: On 30 December 2025, he disposed 1,000,000 ordinary shares at MYR 8.567 per share, representing 0.011% of the total shares.
• Remaining Shareholding: Following these transactions, Mr. Aydinlar continues to hold substantial direct and indirect interests in IHH Healthcare Berhad. His holdings are structured through various nominee accounts, including Citigroup Nominees (Asing) Sdn Bhd and Raffles Nominees (Pte) Limited.

Implications for Shareholders

• Potential Price Sensitivity: Disposal of shares by a Non-Executive Director, especially in substantial amounts, can be a material event for shareholders. Such transactions may signal a change in confidence or personal financial rebalancing, which could influence market sentiment and potentially affect share price.
• Ongoing Significant Holdings: Despite the disposals, Mr. Aydinlar retains significant interests, both direct and indirect, in IHH Healthcare Berhad. His total indirect holdings include:
  • 7,000,000 ordinary shares via Citigroup Nominees (Asing) Sdn Bhd, UBS Switzerland AG
  • 207,620,000 ordinary shares via Raffles Nominees (Pte) Limited
  • 298,601,573 ordinary shares via Citigroup Nominees (Asing) Sdn Bhd, UBS Switzerland AG for SZA Gayrimenkul Yatirim Insaat ve Ticaret Anonim Sirketi

  His direct interests also include additional tranches of shares held through nominee accounts.

• Transaction Timing: These disposals were made outside the closed period, indicating regulatory compliance and transparency in reporting.

Details of Shareholding Structure

Mr. Aydinlar’s holdings are managed through multiple nominee accounts, which may be relevant for investors tracking substantial shareholders and any changes in substantial interests. The breakdown is as follows:

• Direct Interest:
  • Citigroup Nominees (Asing) Sdn Bhd, nominee of UBS Switzerland AG: 7,000,000 ordinary shares
  • Citigroup Nominees (Asing) Sdn Bhd, UBS Switzerland AG for Mehmet Ali Aydinlar: 948,000 ordinary shares
• Indirect Interest:
  • Citigroup Nominees (Asing) Sdn Bhd, nominee of UBS Switzerland AG: 7,000,000 ordinary shares
  • Raffles Nominees (Pte) Limited: 207,620,000 ordinary shares
  • Citigroup Nominees (Asing) Sdn Bhd, UBS Switzerland AG for SZA Gayrimenkul Yatirim Insaat ve Ticaret Anonim Sirketi: 298,601,573 ordinary shares

What Shareholders Should Watch For

• Director’s Changing Position: While the recent disposals are relatively small fractions of the total shares, repeated or larger disposals by directors can influence market perceptions and may be interpreted by some investors as a signal regarding future company prospects.
• Market Reaction: Investors should monitor trading volumes and price movements in IHH Healthcare shares following this announcement to gauge market sentiment.
• Transparency and Compliance: The company has fulfilled its obligations by announcing these dealings outside the closed period, ensuring transparency for all stakeholders.

Conclusion

The disposal of shares by Mr. Mehmet Ali Aydinlar, a Non-Executive Director of IHH Healthcare Berhad, is a noteworthy event for investors. While the amount disposed is small relative to the total share capital, such transactions can be price-sensitive and warrant close monitoring, especially if followed by further disposals or changes in director holdings. Mr. Aydinlar continues to be a substantial shareholder both directly and indirectly, which remains a positive signal for long-term holders.

Disclaimer: This article is for informational purposes only and should not be taken as investment advice. Investors should conduct their own due diligence and consult professional advisors before making any investment decisions. The author is not responsible for any trading decisions based on this article.

View IHH Historical chart here